Calreticulin, an endoplasmic reticulum-resident protein, is highly expressed and essential for cell proliferation and migration in oral squamous cell carcinoma

Wei‐Fan Chiang, Tzer-Zen Hwang, Tzyh‐Chyuan Hour, +8

Oral Oncology

Endoplasmic Reticulum-resident ProteinMalignant DiseaseCancer GrowthPathologyCell Proliferation +6

Comparison between conventional and intensity-modulated post-operative radiotherapy for stage III and IV oral cavity cancer in terms of treatment results and toxicity

Wen‐Cheng Chen, Tzer-Zen Hwang, Wen–Hung Wang, +6

Oral Oncology

Adaptive RadiotherapySurgical OncologyRadiation TherapyMedicineTreatment Results +8

The benefit of pretreatment esophageal screening with image-enhanced endoscopy on the survival of patients with hypopharyngeal cancer

Wen‐Lun Wang, Cheng‐Ping Wang, Hsiu‐Po Wang, +15

Oral Oncology

EndoscopyPretreatment EsophagealEndoscopic ImagingMedical ImagingHypopharyngeal Cancer +10

eIF4E and 4EBP1 are prognostic markers of head and neck squamous cell carcinoma recurrence after definitive surgery and adjuvant radiotherapy

Chung‐I Huang, Chih-Chun Wang, Tzong-Shyuan Tai, +4

PLoS ONE

Surgical OncologyPathologyCancer BiologyTumor BiologyOncology +15

Outcomes of patients with nasopharyngeal carcinoma treated with intensity-modulated radiotherapy

Shyh‐An Yeh, Tzer-Zen Hwang, Chih-Chun Wang, +11

Journal of Radiation Research

A nationwide population-based study to access the risk of metachronous esophageal cancers in head and neck cancer survivors

Chao‐Ming Tseng, Hsi‐Hao Wang, Ching‐Tai Lee, +10

Scientific Reports

Comparative clinical outcomes of Taiwanese patients with resected buccal and tongue squamous cell carcinomas

Chun‐Ta Liao, Yu‐Wen Wen, Lan‐Yan Yang, +28

Oral Oncology

Surgical OncologyEsophageal CancerMedicineComparative Clinical OutcomesPathology +6

The Impact of Insurance and Marital Status on Survival in Patients with Nasopharyngeal Carcinoma

Chih-Chun Wang, Ching‐Chieh Yang, Shyh‐An Yeh, +4

Biology

Treatment Sequences in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Cetuximab Followed by Immunotherapy or Vice Versa

Chuan‐Chien Yang, Ching‐Feng Lien, Tzer-Zen Hwang, +5

Cancers